Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer

Research output: Contribution to journalReview articlepeer-review

6 Citations (Scopus)
21 Downloads (Pure)


Metabolic remodelling is a hallmark of cancer, however little has been unravelled in its role in chemoresistance, which is a major hurdle to cancer control. Lung cancer is a leading cause of death by cancer, mainly due to the diagnosis at an advanced stage and to the development of resistance to therapy. Targeted therapeutic agents combined with comprehensive drugs are commonly used to treat lung cancer. However, resistance mechanisms are difficult to avoid. In this review, we will address some of those therapeutic regimens, resistance mechanisms that are eventually developed by lung cancer cells, metabolic alterations that have already been described in lung cancer and putative new therapeutic strategies, and the integration of conventional drugs and genetic and metabolic-targeted therapies. The oxidative stress is pivotal in this whole network. A better understanding of cancer cell metabolism and molecular adaptations underlying resistance mechanisms will provide clues to design new therapeutic strategies, including the combination of chemotherapeutic and targeted agents, considering metabolic intervenients. As cancer cells undergo a constant metabolic adaptive drift, therapeutic regimens must constantly adapt.

Original languageEnglish
Article number603
Issue number12
Publication statusPublished - 29 Nov 2019


  • lung cancer
  • cancer metabolism
  • reactive oxygen species (ROS)
  • therapy resistance
  • new therapeutic strategies


Dive into the research topics of 'Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer'. Together they form a unique fingerprint.

Cite this